Luca Schiliró Tristão
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Luca Schiliró Tristão has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Wanderley Marques Bernardo
Universidade de São Paulo, Brazil
11 shared publications - Clara Lucato dos Santos
Departamento de Pediatria, Irmandade da Santa Casa de São Paulo, São Paulo, SP, Brazil
10 shared publications - Francisco Tustumi
Department of Health Sciences, Hospital Israelita Albert Einstein, São Paulo, Brazil
4 shared publications Ana Clara Pimenta Servidoni
3 shared publications- Antonio Silvinato
Brazilian Medical Association, Brazil
3 shared publications Berenice Curi-Pesantes
3 shared publications
Latest Publications
- 12 November 2026
- Published by Elsevier in Journal of Minimally Invasive Gynecology
Author's Reply
- 28 October 2026
- Published by Elsevier in Journal of Minimally Invasive Gynecology
Author's Reply
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (1) , e2024D711
The use of dupilumab in children and adolescents with severe atopic dermatitis: a systematic review and meta-analysis
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (1) , e2024D711
Open AccessThe use of dupilumab in children and adolescents with severe atopic dermatitis: a systematic review and meta-analysis
The Guidelines Project, an initiative of the Brazilian Medical Association, aims to combine information from the medical field to standardize how to conduct, and to assist in the reasoning and decision-making of doctors. The information provided by this project must be critically evaluated by the physician responsible for the conduct that will be adopted, depending on the conditions and the clinical condition of each patient.
- Open Access
- 20 December 2024
- Vol. 43, e2024115
Effects of enteral insulin on enteral diet tolerance in premature infants: systematic review
The primary objective of this systematic review was to evaluate the effect of enteral insulin supplementation provided to premature newborns on the time to achieve full enteral feeding. Secondary objectives included evaluating the effects on weight gain, the occurrence of adverse events, and mortality. A systematic review of randomized clinical trials was conducted using the databases PubMed, Scientific Electronic Library Online (SciELO), clinicaltrials.gov, Embase, and Latin American and Caribbean Health Sciences Literature (Lilacs). The review was registered in PROSPERO under CRD42024523021. Premature newborns receiving enteral and parenteral nutrition who were given either breast milk or formula milk supplemented with enteral insulin as intervention, compared with placebo, were included. After applying the eligibility criteria, two articles were selected for this study. The two studies included in this review identified a reduced time to achieve full enteral feeding. Regarding secondary outcomes, there was a reduction in the number of days receiving parenteral nutrition and a reduction in adverse events and mortality. However, there was no agreement among the studies concerning weight gain. Enteral insulin appears to be an effective treatment for reducing the time to achieve full enteral feeding. However, more studies are necessary to recommend its use in clinical practice.
- 20 December 2024
- Vol. 43, e2024115
Open AccessEffects of enteral insulin on enteral diet tolerance in premature infants: systematic review
The primary objective of this systematic review was to evaluate the effect of enteral insulin supplementation provided to premature newborns on the time to achieve full enteral feeding. Secondary objectives included evaluating the effects on weight gain, the occurrence of adverse events, and mortality. A systematic review of randomized clinical trials was conducted using the databases PubMed, Scientific Electronic Library Online (SciELO), clinicaltrials.gov, Embase, and Latin American and Caribbean Health Sciences Literature (Lilacs). The review was registered in PROSPERO under CRD42024523021. Premature newborns receiving enteral and parenteral nutrition who were given either breast milk or formula milk supplemented with enteral insulin as intervention, compared with placebo, were included. After applying the eligibility criteria, two articles were selected for this study. The two studies included in this review identified a reduced time to achieve full enteral feeding. Regarding secondary outcomes, there was a reduction in the number of days receiving parenteral nutrition and a reduction in adverse events and mortality. However, there was no agreement among the studies concerning weight gain. Enteral insulin appears to be an effective treatment for reducing the time to achieve full enteral feeding. However, more studies are necessary to recommend its use in clinical practice.
- Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review
Background: Metabolic dysfunction-associated liver disease (MASLD) and alcohol-associated liver disease (ALD) are among the leading causes of liver disease worldwide. The exact roles of epigenetic factors in both diseases remains largely unknown. In this context, liver DNA methylation remains a field that requires further exploration and understanding. Methods: We performed a systematic review of liver DNA methylation in humans with MASLD or ALD using Ovid MEDLINE, Ovid Embase, and Cochrane Library. We included human studies where liver DNA methylation was assessed in patients with MASLD and/or ALD. The Rayyan platform was used to select studies. Risk of bias was assessed with the “risk of bias in non-randomized studies of interventions” tool, ROBINS-I. We performed pathway analysis using the most important differentially methylated genes selected in each article. Results: Fifteen articles were included in this systematic review. The risk of bias was moderate to serious in all articles and bias due to confounding and patient selection was high. Sixteen common pathways, containing differentially methylated genes, including cancer pathways, were identified in both diseases. Conclusions: There are common pathways, containing differentially methylated genes, in ALD and MASLD, such as pathways in cancer and peroxisome proliferator-activated receptor (PPAR) signaling pathways. In MASLD, the insulin signaling pathway is one of the most important, and in ALD, the MAPK signaling pathway is the most important. Our study adds one more piece to the puzzle of the mechanisms involved in steatotic liver disease.
Open AccessMetabolic Dysfunction-Associated Steatotic Liver Disease and Alcohol-Associated Liver Disease: Liver DNA Methylation Analysis—A Systematic Review
Background: Metabolic dysfunction-associated liver disease (MASLD) and alcohol-associated liver disease (ALD) are among the leading causes of liver disease worldwide. The exact roles of epigenetic factors in both diseases remains largely unknown. In this context, liver DNA methylation remains a field that requires further exploration and understanding. Methods: We performed a systematic review of liver DNA methylation in humans with MASLD or ALD using Ovid MEDLINE, Ovid Embase, and Cochrane Library. We included human studies where liver DNA methylation was assessed in patients with MASLD and/or ALD. The Rayyan platform was used to select studies. Risk of bias was assessed with the “risk of bias in non-randomized studies of interventions” tool, ROBINS-I. We performed pathway analysis using the most important differentially methylated genes selected in each article. Results: Fifteen articles were included in this systematic review. The risk of bias was moderate to serious in all articles and bias due to confounding and patient selection was high. Sixteen common pathways, containing differentially methylated genes, including cancer pathways, were identified in both diseases. Conclusions: There are common pathways, containing differentially methylated genes, in ALD and MASLD, such as pathways in cancer and peroxisome proliferator-activated receptor (PPAR) signaling pathways. In MASLD, the insulin signaling pathway is one of the most important, and in ALD, the MAPK signaling pathway is the most important. Our study adds one more piece to the puzzle of the mechanisms involved in steatotic liver disease.
- 4 April 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (5) , 1917-1928
Medium and Long-Term Weight Loss After Revisional Bariatric Surgery: A Systematic Review and Meta-Analysis
Despite the current increase in revisional bariatric surgery (RBS), data on the sustainability of weight loss remain unclear. A systematic review and meta-analysis were performed to assess weight loss outcomes in adult patients undergoing RBS with follow-up > 2 years. Twenty-eight observational studies (n = 2213 patients) were included. The %TWL was 27.2 (95%CI = 23.7 to 30.6), and there was a drop in BMI of 10.2 kg/m2 (95%CI = − 11.6 to − 8.7). The %EWL was 54.8 (95%CI = 47.2 to 62.4) but with a high risk of publication bias (Egger’s test = 0.003). The overall quality of evidence was very low. Our data reinforce that current evidence on RBS is mainly based on low-quality observational studies, and further higher-quality studies are needed to support evidence-based practice. Graphical Abstract
- 4 April 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (5) , 1917-1928
Medium and Long-Term Weight Loss After Revisional Bariatric Surgery: A Systematic Review and Meta-Analysis
Despite the current increase in revisional bariatric surgery (RBS), data on the sustainability of weight loss remain unclear. A systematic review and meta-analysis were performed to assess weight loss outcomes in adult patients undergoing RBS with follow-up > 2 years. Twenty-eight observational studies (n = 2213 patients) were included. The %TWL was 27.2 (95%CI = 23.7 to 30.6), and there was a drop in BMI of 10.2 kg/m2 (95%CI = − 11.6 to − 8.7). The %EWL was 54.8 (95%CI = 47.2 to 62.4) but with a high risk of publication bias (Egger’s test = 0.003). The overall quality of evidence was very low. Our data reinforce that current evidence on RBS is mainly based on low-quality observational studies, and further higher-quality studies are needed to support evidence-based practice. Graphical Abstract
- Open Access
Screening and diagnostic tools for autism spectrum disorder: Systematic review and meta-analysis